Peculiarities of chronic heart failure in COPD patients

2021 ◽

Vol 5 (4) ◽

pp. 199-206

Author(s):

Naomi Kayauchi ◽

Eiji Ojima ◽

Katsunori Kagohashi ◽

Hiroaki Satoh

Keyword(s):

Heart Failure ◽

Body Weight ◽

Respiratory Failure ◽

Chronic Heart Failure ◽

Nutritional Status ◽

Serum Albumin ◽

Oxygen Therapy ◽

Copd Patients ◽

Long Term Oxygen Therapy

Purpose: To investigate the long-term changes in body weight and serum albumin levels in patients with respiratory failure, and those with chronic heart failure, who were treated with home long-term oxygen therapy (LTOT) to understand the current status and contribute to future measures. Methods: Patients with chronic obstructive pulmonary disease (COPD), those with interstitial pneumonia (IP), and those with chronic heart failure (CHF) undergoing home LTOT for 6 months or more between January 2011 and January 2019 were included in the study. Body weight and serum albumin levels were assessed at the start of home LTOT and at the end of the observation period, a minimum of 6 months after commencing home LTOT. Results: Sixty-two patients (29 COPDs, 23 IPs, and 10 CHFs) were included. In COPD patients and IP patients, body weight decreased (P = 0.0017, P = 0.0018, respectively, Wilcoxon signed-rank test). Serum albumin levels decreased in IP patients (P = 0.0185) but not in COPD patients. There was neither significant decrease in body weight nor serum albumin levels in patients with CHF. Conclusion: Chronic respiratory failure patients who have home LTOT were likely to have a decreased nutritional status. In order to provide prolonged home LTOT, medical staff need to pay close attention to the nutritional status of patients receiving home LTOT.

Download Full-text

B-type natriuretic peptide in diagnosis of chronic heart failure in copd patients

Clinical Practice ◽

10.17816/clinpract83625 ◽

2011 ◽

Vol 2 (4) ◽

pp. 29-34

Author(s):

Svetlana P. Tertichnaya ◽

Vera N. Parshukova

Keyword(s):

Heart Failure ◽

Differential Diagnosis ◽

Chronic Heart Failure ◽

Natriuretic Peptide ◽

Copd Patients

The influence of chronic heart failure (CHF) on the В-type natriuretic peptide (BNP) level and BNP role in differential diagnosis of dyspnea in COPD and CHF was estimated.

Download Full-text

Clinical and functional cardiovascular disorders in patients with chronic obstructive pulmonary disease and chronic heart failure

Russian Pulmonology ◽

10.18093/0869-0189-2008-0-2-62-67 ◽

2008 ◽

pp. 62-67

Author(s):

Ya. N. Shoikhet ◽

E. B. Klester

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Stable Angina ◽

Clinical Signs ◽

Left Ventricular ◽

Class I ◽

Chronic Obstructive ◽

Class Iii ◽

Copd Patients ◽

Number Of Patients

The study was aimed to investigate clinical and functional particularities of cardiovascular system in patients with COPD and chronic heart failure (CHF). We examined 1737 patients, of them, 498 with COPD (the 1st group), 721 with COPD and concomitant class I to III stable angina (the 2nd group), and 519 with class I to III stable angina (the 3rd group). All the patients also had CHF. The study included clinical assessment using modified R. Cody's scale, ECG, Holter monitoring, lung function testing, Doppler echocardiography, 6-minute walk test (6MWT). Obstructive disorders were found in 424 of the 2nd group patients (58.8 %) and 268 of the 3rd group patients (51.7 %). Number of patients with class II to IV chronic cor pulmonale was similar in all groups. The class III was determined more often in the 2nd group (36.5 %; р < 0.05), the class I prevailed in the 1st group (17.8 %; р < 0.05). The stage I CHF predominated in the 1st group (31.9 %; р < 0.05), the stages IIА and IIБ were seen mainly in the 2nd group (51.6 % and 26.4 % respectively; р < 0.05). The majority of the 3rd group patients (57.3 %) had the stage IIA CHF. According to most clinical signs, CHF was more severe in the 2nd group. 6MWT was 308.08 ± 6.03 m in the 1st group, 156.4 ± 4.38 m in the 2nd group, and 212.8 ± 5.65 m in the 3rd group (р < 0.05). Low left ventricular (LV) ejection fraction was seen significantly more often in COPD patients with concomitant angina. This group as well as COPD patients had significantly higher mean pulmonary artery pressure (mPAP) (24.7 ± 0.41 mm Hg and 29.9 ± 0.27 mm Hg respectively) compared to 21.7 ± 0.07 mm Hg in the 3rd group patients. Right ventricular (RV) diastolic dysfunction was revealed in 154 patients of the 1st group (83.7 %), 194 patients of the 2nd group (91.9 %) and 72 patients of the 3rd group (43.1 %). In conclusion, all the patients had RV and LV remodeling signs. COPD patients had more prominent RV hypertrophy and dilation, angina patients had enlargement of left heart and moderate decrease in LV contractility. The patients with COPD and angina had the greatest increase in size and wall thickness of both LV and RV and low pump function of LV.

Download Full-text